Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review

Developing multiple soft tissue sarcomas (STSs) is a rare process, sparsely reported in the literature to date. Little is known about the pattern of disease development or outcomes in these patients. Patients were identified from three tertiary orthopaedic oncology centres in Canada and the UK. Pati...

Full description

Bibliographic Details
Main Authors: Johnathan R. Lex, Ahmed Aoude, Jonathan D. Stevenson, Jay S. Wunder, Scott Evans, Peter C. Ferguson, Nikolaos A. Stavropoulos, Lee Jeys, Krista Goulding, Robert E. Turcotte
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:Sarcoma
Online Access:http://dx.doi.org/10.1155/2018/5392785
id doaj-b0125d17c430465bba34640a5a121853
record_format Article
spelling doaj-b0125d17c430465bba34640a5a1218532020-11-24T22:35:22ZengHindawi LimitedSarcoma1357-714X1369-16432018-01-01201810.1155/2018/53927855392785Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre ReviewJohnathan R. Lex0Ahmed Aoude1Jonathan D. Stevenson2Jay S. Wunder3Scott Evans4Peter C. Ferguson5Nikolaos A. Stavropoulos6Lee Jeys7Krista Goulding8Robert E. Turcotte9University of Birmingham, Birmingham B15 2TT, UKMcGill University Health Centre, Montreal, QC, H4A 3J1, CanadaRoyal Orthopaedic Hospital, Birmingham B31 2AP, UKUniversity of Toronto Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, ON, M5G 1X5, CanadaRoyal Orthopaedic Hospital, Birmingham B31 2AP, UKUniversity of Toronto Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, ON, M5G 1X5, CanadaMcGill University Health Centre, Montreal, QC, H4A 3J1, CanadaRoyal Orthopaedic Hospital, Birmingham B31 2AP, UKMcGill University Health Centre, Montreal, QC, H4A 3J1, CanadaMcGill University Health Centre, Montreal, QC, H4A 3J1, CanadaDeveloping multiple soft tissue sarcomas (STSs) is a rare process, sparsely reported in the literature to date. Little is known about the pattern of disease development or outcomes in these patients. Patients were identified from three tertiary orthopaedic oncology centres in Canada and the UK. Patients who developed multiple extremity STSs were collated retrospectively from prospective oncology databases. A literature review using MEDLINE was also performed. Six patients were identified in the case series from these three institutions, and five studies were identified from the literature review. Overall, 17 patients were identified with a median age of 51 years (range: 19 to 77). The prevalence of this manifestation in STS patients is 1 in 1225. The median disease-free interval between diagnoses was 2.3 years (range: 0 to 19 years). Most patients developed the secondary STS in a metachronous pattern, the remaining, synchronously. The median survival after the first sarcoma was 6 years, and it was 1.6 years after the second sarcoma. The 5-year overall survival rate was 83.3% and 50% following the first and second STS diagnoses, respectively. A diagnosis of two STSs does not confer a worse prognosis than the diagnosis of a single STS. Developing a second STS is a rare event with no identifiable histological pattern of occurrence. Presentation in a metachronous pattern is more common. A high degree of vigilance is required in patients with a previous STS both to detect both local recurrence and to identify new masses remote from the previous STS site. Acquiring an early histological diagnosis should be attempted.http://dx.doi.org/10.1155/2018/5392785
collection DOAJ
language English
format Article
sources DOAJ
author Johnathan R. Lex
Ahmed Aoude
Jonathan D. Stevenson
Jay S. Wunder
Scott Evans
Peter C. Ferguson
Nikolaos A. Stavropoulos
Lee Jeys
Krista Goulding
Robert E. Turcotte
spellingShingle Johnathan R. Lex
Ahmed Aoude
Jonathan D. Stevenson
Jay S. Wunder
Scott Evans
Peter C. Ferguson
Nikolaos A. Stavropoulos
Lee Jeys
Krista Goulding
Robert E. Turcotte
Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review
Sarcoma
author_facet Johnathan R. Lex
Ahmed Aoude
Jonathan D. Stevenson
Jay S. Wunder
Scott Evans
Peter C. Ferguson
Nikolaos A. Stavropoulos
Lee Jeys
Krista Goulding
Robert E. Turcotte
author_sort Johnathan R. Lex
title Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review
title_short Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review
title_full Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review
title_fullStr Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review
title_full_unstemmed Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review
title_sort multiple soft tissue sarcomas in a single patient: an international multicentre review
publisher Hindawi Limited
series Sarcoma
issn 1357-714X
1369-1643
publishDate 2018-01-01
description Developing multiple soft tissue sarcomas (STSs) is a rare process, sparsely reported in the literature to date. Little is known about the pattern of disease development or outcomes in these patients. Patients were identified from three tertiary orthopaedic oncology centres in Canada and the UK. Patients who developed multiple extremity STSs were collated retrospectively from prospective oncology databases. A literature review using MEDLINE was also performed. Six patients were identified in the case series from these three institutions, and five studies were identified from the literature review. Overall, 17 patients were identified with a median age of 51 years (range: 19 to 77). The prevalence of this manifestation in STS patients is 1 in 1225. The median disease-free interval between diagnoses was 2.3 years (range: 0 to 19 years). Most patients developed the secondary STS in a metachronous pattern, the remaining, synchronously. The median survival after the first sarcoma was 6 years, and it was 1.6 years after the second sarcoma. The 5-year overall survival rate was 83.3% and 50% following the first and second STS diagnoses, respectively. A diagnosis of two STSs does not confer a worse prognosis than the diagnosis of a single STS. Developing a second STS is a rare event with no identifiable histological pattern of occurrence. Presentation in a metachronous pattern is more common. A high degree of vigilance is required in patients with a previous STS both to detect both local recurrence and to identify new masses remote from the previous STS site. Acquiring an early histological diagnosis should be attempted.
url http://dx.doi.org/10.1155/2018/5392785
work_keys_str_mv AT johnathanrlex multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview
AT ahmedaoude multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview
AT jonathandstevenson multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview
AT jayswunder multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview
AT scottevans multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview
AT petercferguson multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview
AT nikolaosastavropoulos multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview
AT leejeys multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview
AT kristagoulding multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview
AT roberteturcotte multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview
_version_ 1725723741265068032